Zhiping Guo

机构：Fujian Medical University, First Affiliated Hospital of Fujian Medical University, Zhengzhou Central Hospital · ORCID：0000-0003-0454-1149

发表论文 43 篇 · 总被引 621 次 · h-index 15

代表论文

• Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways (2019 · Inflammopharmacology · 被引 138)
• Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway (2018 · International Journal of Molecular Medicine · 被引 92)
• Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma (2019 · Molecular Carcinogenesis · 被引 37)
• Early and Quantitative Assessment of Myocardial Deformation in Essential Hypertension Patients by Using Cardiovascular Magnetic Resonance Feature Tracking (2020 · Scientific Reports · 被引 34)
• Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events (2020 · Oxidative Medicine and Cellular Longevity · 被引 26)
• Molecular characterization of a MOSPD2 homolog in the barbel steed (Hemibarbus labeo) and its involvement in monocyte/macrophage and neutrophil migration (2020 · Molecular Immunology · 被引 23)